Skip to main content
OpenTrials

Clinical trial condition

FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma

Explore clinical trials studying FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma trial results

Completed

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

NCT03018249

Conditions
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
Locations
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • John Muir Medical Center-Concord Campus Concord, California, United States
  • John Muir Medical Center-Walnut Creek Walnut Creek, California, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
View all 234 locations
View Trial Details

Related conditions